Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.94M

combined est. value

Stock	Shares	Price	Value	Weight	As of
CGEMCullinan Therapeutics, Inc.	126,380	$15.36	$1.94M	100%	2026-02-20

CGEM

Cullinan Therapeutics, Inc.

$1.94M

126,380 sh

All filings on record

Every Form 4 transaction we track for this filer

all 3buys 0sells 1

Stock	Transaction	Date	~6mo later
CGEMCullinan Therapeutics, Inc.	Sell $59.9K · 4,398 sh	2026-02-20	—
CGEMCullinan Therapeutics, Inc.	Grant — · 68,750 sh	2026-02-18	—
CGEMCullinan Therapeutics, Inc.	Grant $175.23 · 27 sh	2025-12-31	—

CGEMSell

2026-02-20 · Cullinan Therapeutics, Inc.

$59.9K

—

CGEMGrant

2026-02-18 · Cullinan Therapeutics, Inc.

68,750

—

CGEMGrant

2025-12-31 · Cullinan Therapeutics, Inc.

$175.23

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.